Galderma to collaborate with Mentor Worldwide

Galderma has announced a nationwide collaboration with Mentor Worldwide to help healthcare specialists broaden consumers’ access to and awareness of available aesthetic treatment options. The initiative will focus on professionals who have shared patients looking for aesthetic injectable treatments and breast enhancement. According to data released with the companies statement, 33% of women who have had injectable treatments have also had breast augmentation

Relevance: The collaboration includes Galderma’s aesthetic brands, including Sculptra Aesthetic.

Save

This article is more than 5 years old. Information may no longer be current.

Galderma, Mentor announce collaboration on facial rejuvenation, breast augmentation

ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on . Please provide your email address to receive an email when new articles are posted on Subscribe ADDED TO EMAIL ALERTS You've successfully added to your alerts. You will receive an email when new content is published.



Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published.



Click Here to Manage Email Alerts



Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.



Back to Healio

Galderma and Mentor Worldwide LLC announced in a press release a nationwide collaboration to partner with surgeons for advancing patient experiences across the companies’ facial rejuvenation and breast augmentation brand offerings.

“This collaboration with Mentor demonstrates our commitment to being partner of choice within the aesthetics industry and furthers our goal of providing long-term value to health care specialists while broadening consumers’ access to and awareness of their aesthetic treatment options,” Kelly Huang, PhD, vice president and general manager, Aesthetic & Corrective Business Unit, Galderma, US, stated in the release.

The companies’ collaboration will focus on health care professionals who have shared patients looking for aesthetic injectable treatments and breast enhancement. Data show that up to 33% of women who have had injectable treatments also have had breast augmentation, according to the release.

The collaboration incudes Galderma’s aesthetic brands, including Restylane fillers, Dysport (abobotulinumtoxinA) 300 units for injection and Sculptra Aesthetic, along with Mentor MemoryShape and MemoryGel breast implants portfolio for the U.S. aesthetics market, according to the release.

“This in an ideal collaboration that will enable me to offer greater value and choice to my patients — many of whom are interested in both breast enhancement and facial rejuvenation — and who trust me to utilize best-in-class aesthetic treatment options,” Christopher Saunders, MD, PA, board-certified plastic surgeon in Delaware, stated in the release.

Reference: www.galdermausa.com